ATS 2024 Final Program

Click on the session title to view the speakers

218

MONDAY • MAY 20

308 Investigating the Factors Underlying Radiologist Variation in Pulmonary Nodules Recommendation 309 Evaluation of the Impact of Positron Emission Tomography on the Malignancy Probability of Lung Nodules 310 The Value of Artificial Intelligence Versus Traditional Lung Cancer Risk Prediction Models for Ground-glass and Pure-solid Pulmonary Nodules in Asia 311 Diagnostic Yield of Robotic Bronchoscopy in a Large, Multi-site Institution With Long-term Follow-up: A Focus on the Indeterminate Result 312 Therapeutic Bronchoscopy for Malignant Central Airway Obstruction Complicating Non-bronchogenic Cancers: Results From the Epigetif Registry 313 Comparing Primary Treatment Modalities for Stage 1A Non-small Cell Lung Cancer in US Veterans: Resection Versus Microwave Ablation Versus Stereotactic Body Radiation Therapy 314 Systematic Endoscopic Staging of Mediastinum to Determine Impact on Radiotherapy for Locally Advanced Lung Cancer (seismic): An International Multicentre Single-arm Clinical Trial 315 Comparative Effectiveness of Stereotactic Body Radiation Therapy Versus Wedge Resection in Long-term Health Outcomes in Early-stage Lung Cancer

ATS 2024 Conference Program • San Diego, CA